Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis

Journal of Immunology

Volumn 152, Issue 10, 1994, Pages 5000-5008

  Qian, Qinfang ^a   Jutila, Mark A ^a   Van Rooijen, Nico ^b   Cutler, Jim E ^a  

^a MONTANA STATE UNIVERSITY   (United States)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; THIOGLYCOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; CORRELATION FUNCTION; EXPERIMENTAL INFECTION; FEMALE; INFECTION RESISTANCE; INFECTION SENSITIVITY; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; NUDE MOUSE; PHAGOCYTOSIS; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; BLOOD CELL COUNT; CANDIDIASIS; CLODRONIC ACID; DISEASE SUSCEPTIBILITY; FEMALE; FUNGEMIA; IMMUNOENZYME TECHNIQUES; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; NEUTROPHILS; PHAGOCYTOSIS;

EID: 0028223193     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Lertratanakul, Y., G. H. Glassford, and H. M. Rubinstein. 1977. Arthritis and osteomyelitis due to Candida albicans: a case report. J. Rheumatol. 4:317.
2. Maksymiuk, A. W., S. Thongprasert, R. Hopfer, M. Luna, V. Fainstein, and G. P. Bodey. 1984. Systemic candidiasis in cancer patients. Am. J. Med. October:20.
3. Wey, S. B., M. Mori, M. A. Pfaller, R. F. Woolson, and R. P. Wenzel. 1989. Risk factors for hospital-acquired candidemia. Arch. Intern. Med. 149:2349.
4. Laine, L., M. Bonacini, F. Sattler, T. Young, and A. Sherrod. 1992. Cytomegalovirus and Candida esophagitis in patients with AIDS. J. Acquired Immune Defic. Syndr. 5:605.
5. Thaler, M., B. Pastakia, T. H. Shawker, T. O'Leary, and P. A. Pizzo. 1988. Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann. Intern. Med. 108:88.
6. + lymphocytes in resistance to mucosal candidiasis. Infect. Immun. 59:2447.
7. Valdimarsson, H., J. M. Higgs, R. S. Wells, M. Yamamura, J. R. Hobbs, and P. J. L. Holt. 1973. Immune abnormalities associated with chronic mucocutaneous candidiasis. Cell. Immunol. 6:348.
8. Cenci, E., L. Romani, A. Vecchiarelli, P. Puccetti, and F. Bistoni. 1989. Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice. Infect. Immun. 57:3581.
9. Sieck, T. G., M. A. Moors, H. R. Buckley, and K. J. Blank. 1993. Protection against murine disseminated candidiasis mediated by a Candida albicans-specific T-cell line. Infect. Immun. 61:3540.
10. Lee, K. W., and E. Balish. 1981. Systemic candidosis in germfree, flora-defined and conventional nude and thymus-bearing mice. J. Reticuloendothel. Soc. 29:71.
11. Cutler, J. E. 1976. Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice. J. Reticuloendothel. Soc. 19:121.
12. Miyake, T., K. Takeya, K. Nomoto, and S. Muraoka. 1977. Cellular elements in the resistance to Candida infection in mice. I. Contribution of T lymphocytes and phagocytes at various stages of infection. Microbiol. Immunol. 21:703.
13. Rogers, T. J., E. Balish, and D. D. Manning. 1976. The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis. J. Reticuloendothel. Soc. 20:291.
14. Cockayne, A. and F. C. Odds. 1984. Interactions of Candida albicans yeast cells, germ tubes and hyphae with human polymorphonuclear leukocytes in vitro. J. Gen. Microbiol. 130:465.
15. Marquis, G., S. Garzon, S. Montplaisir, H. Strykowski, and N. Benhamou. 1991. Histochemical and immunochemical study of the fate of Candida albicans inside human neutrophil phagolysosomes. J. Leukocyte Biol. 50:587.
16. Rogers, T. J., and E. Balish. 1977. The role of activated macrophages in resistance to experimental renal candidiasis. J. Reticuloendothel. Soc. 22:309.
17. Baghian, A., and K. W. Lee. 1989. Systemic candidosis in beige mice. J. Med. Vet. Mycol. 27:51.
18. Verdeguer, A., J. M. Fernandez, C. Esquembre, J. Ferris, J. E. Ruiz, and V. Castel. 1990. Hepatosplenic candidiasis in children with acute leukemia. Cancer 65:874.
19. Brummer, E., and D. A. Stevens. 1989. Candidacidal mechanisms of peritoneal macrophages activated with lymphokines or gamma-interferon. J. Med. Microbiol. 28:173.
20. Morrison, R. P., and J. E. Cutler. 1981. In vitro studies of the interaction of murine phagocytic cells with Candida albicans. J. Reticuloendothel. Soc. 29:23.
21. Redmond, H. P., J. Shou, H. J. Gallagher, C. J. Kelly, and J. M. Daly. 1993. Macrophage-dependent candidacidal mechanisms in the murine system: comparison of murine Kupffer cell peritoneal macrophage candidacidal mechanisms. J. Immunol. 150:3427.
22. Cutler, J. E., and A. H. Poor. 1981. Effect of mouse phagocytes on Candida albicans in in vivo chambers. Infect. Immun. 31:1110.
23. Sawyer, R. T. 1990. Experimental pulmonary candidiasis. Mycopathologia 109:99.
24. Sawyer, R. T., R. E. Garner, and J. A. Hudson. 1992. Effect of lectins on hepatic clearance and killing of Candida albicans by the isolated perfused mouse liver. Infect. Immun. 60:1041.
25. Sawyer, R. T., R. E. Garner, and J. A. Hudson. 1992. Arg-gly-asp (RGD) peptides alter hepatic killing of Candida albicans in the isolated perfused mouse liver model. Infect. Immun. 60:213.
26. Janusz, M. J., K. F. Austen, and J. K. Czop. 1988. Phagocytosis of heat-killed blastospores of Candida albicans by human monocyte β-glucan receptors. Immunology 65:181.
27. Marodi, L., H. M. Korchak, and R. B. Johnston. 1991. Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. J. Immunol. 146:2783.
28. Hashimoto, T. 1991. In vitro study of contact-mediated killing of Candida albicans hyphae by activated murine peritoneal macrophages in a serum-free medium. Infect. Immun. 59:3555.
29. Wang, M., H. Friedman, and J. Y. Djeu. 1989. Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF. J. Immunol. 143:671.
30. Baghian, A., and K. W. Lee. 1988. Role of activated macrophages in resistance to systemic candidosis. J. Leukocyte Biol. 44:166.
31. Bistoni, F., A. Vecchiarelli, E. Cenci, P. Puccetti, P. Marconi, and A. Cassone. 1986. Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect. Immun. 51:668.
32. Garner, R. E., U. Kuruganti, C. W. Czarniecki, H. H. Chiu, and J. E. Domer. 1989. In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon. Infect. Immun. 57:1800.
33. Kullberg, B.-J., J. W. Van't Wout, C. Hoogstraten, and R. van Furth. 1993. Recombinant interferon-τ enhances resistance to acute disseminated Candida albicans infection in mice. J. Infect. Dis. 168:436.
34. Lee, K. W., and E. Balish. 1983. Systemic candidosis in silica-treated athymic and euthymic mice. Infect. Immun. 41:902.
35. Hume, D. A., and Y. Denkins. 1992. The deleterious effect of macrophage colony-stimulating factor (CSF-1) on the pathology of experimental candidiasis in mice. Lymphokine Cytokine Res. 11:95.
36. van Rooijen, N. 1991. Liposome-mediated elimination of macrophages. Res. Immunol. 142:215.
37. van Rooijen, N., and E. Claassen. 1988. In vivo elimination of macrophages in spleen and liver, using liposome-encapsulated drugs: methods and applications. In Liposomes as Drug Carriers. G. Gregoriadis, ed. John Wiley & Sons Ltd., New York pp. 131-143.
38. Li, R. K., and J. E. Cutler. 1993. Chemical definition of an epitope/ adhesin molecule on Candida albicans. J. Biol. Chem. 268:18293.
39. Hazen, K. C., D. L. Brawner, M. H. Riesselman, M. A. Jutila, and J. E. Cutler. 1991. Differential adherence between hydrophobic and hydrophilic yeast cells of Candida albicans. Infect. Immun. 59:907.
40. Su, D., and N. van Rooijen. 1989. The role of macrophages in the immunoadjuvant action of liposomes: effects of elimination of splenic macrophages on the immune response against intravenously injected liposome-associated albumin antigen. Immunology 66:466.
41. Springer, T. A., G. Galfree, D. S. Secher, and C. Milstein. 1979. Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens. Eur. J. Immunol. 9:301.
42. Jutila, M. A., T. K. Kishimoto, and M. Finken. 1991. Low-dose chymotrypsin treatment inhibits neutrophil migration into sites of inflammation in vivo: effects on Mac-1 and MEL-14 adhesion protein expression and function. Cell. Immunol. 132:201.
43. Jutila, M. A., E. L. Berg, F. G. M. Kroese, L. Rott, V. Perry, and E. C. Butcher. 1993. In vivo distribution and characterization of two novel mononuclear phagocyte differentiation antigens in the mouse. J. Leukocyte Biol. 54:30.
44. Gallatin, W. M., I. L. Weissman, and E. C. Butcher. 1983. A cell surface molecule involved in organ-specific homing of lymphocytes. Nature 304:30.
45. Ledbetter, J. A., and L. A. Herzenberg. 1979. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:63.
46. Han, Y., N. van Rooijen, and J. E. Cutler. 1993. Binding of Candida albicans yeast cells to mouse popliteal lymph node tissue is mediated by macrophages. Infect. Immun. 61:3244.
47. Riesselman, M. H., T. Kanbe, and J. E. Cutler. 1991. Improvements and important considerations of an ex vivo assay to study interactions of Candida albicans with splenic tissue. J. Immunol. Methods 1450:153.
48. van Rooijen, N., N. Kors, and G. Kraal. 1989. Macrophage subset repopulation in the spleen: differential kinetics after liposome-mediated elimination. J. Leukocyte Biol. 45:97.
49. Kanbe, T., M. A. Jutila, and J. E. Cutler. 1992. Evidence that Candida albicans binds via a unique adhesion system on phagocytic cells in the marginal zone of the mouse spleen. Infect. Immun. 60:1972.
50. 3H]methotrexate. Biochim. Biophys. Acta 802:428.
51. Kishimoto, T. K., M. A. Jutila, E. L. Berg, and E. C. Butcher. 1989. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 245:1238.
52. Kanbe, T., H. Yongmoon, B. Redgrave, M. H. Riesselman, and J. E. Cutler. 1993. Evidence that mannans of Candida albicans are responsible for adherence of yeast forms to spleen and lymph node tissue. Infect. Immun. 61:2578.
53. Odds, F. C. 1988. Candida and candidosis. Bailliere Tindall, London.
54. Viviani, M. A. 1992. Opportunistic fungal infections in patients with acquired immune deficiency syndrome. Chemotherapy 38(Suppl. 1):35.
55. Souvannavong, V., and A. Adam. 1990. Macrophages from C3H/ HeJ mice require an additional step to produce monokines: synergistic effects of silica and poly(I:C) in the release of interleukin 1. J. Leukocyte Biol. 48:183.
56. Claassen, E., N. Kors, and N. van Rooijen. 1986. Influence of carγδ riers on the development and localization of anti-2,4,6-trinitrophenyl (TNP) antibody-forming cells in the murine spleen. II. Suppressed antibody response to TNP-Ficoll after elimination of marginal zone cells. Eur. J. Immunol. 16:492.
57. Rodriguez-Boulan, E., and W. J. Nelson. 1989. Morphogenesis of the polarized epithelial cell phenotype. Science 245:718.